Do certain pharmacotherapies for IBS increase the risk of mortality?Study examines the risk of all-cause mortality with approved and off-label pharmacotherapies for irritable bowel syndrome (IBS). How to avoid dosing interval errorsSince most medications are taken daily, doses outside that interval have a lot of error potential. Rings a Bell: Anxiety with pharmacist and psychotherapist (qualifying), Rami Safi Are you anxious about what you don’t remember about anxiety therapy? Well have I got a treat for you. Five osteoporosis pearls: Clinical tips for treating men and women ‘The promise of a drug holiday may actually inspire patients to take their bisphosphonate.’ Nit-picking the facts: navigating resistance in head lice Treatment resistance is an emerging challenge requiring pharmacists to employ evidence-based strategies. NEW PRODUCT: Zurzuvae for postpartum depression Get the info you need on this new product, part of our drug news roundup for April. Lookalikes are one thing, but be extra careful when medications are soundalikes at the same time What’s the deal with Diclectin and Dicetel? A reminder from ISMP Canada to watch for these double trouble potential mix-ups. Walmart expands autoimmune care program to 330+ pharmacies nationwide Pharmacist-led initiative aims to improve access to med support for chronic autoimmune conditions. U of T pharmacist helps lead ICU clinical guidelines for older adult care As older adults become a larger share of ICU patients, new guidelines address the lack of research on how treatments affect this population. AGEP: the rare but severe drug reaction pharmacists should know how to recognize Acute generalized exanthematous pustulosis (AGEP) presents with sterile pustules and systemic symptoms, and usually improves within days of stopping the trigger. 1 2 3 4 5 Next Last
